Medically reviewed by David Ozeri, MD Psoriatic arthritis (PsA) develops in four stages: the preclinical stage, where those ...

Tests of the fluid around a joint can help rule out gout or infectious arthritis. Stopping progression of the disease. Reducing inflammation. Treating skin symptoms. Relieving pain. Keeping joints as ...

The inflammation can affect the entire body and may lead to permanent joint and tissue damage if it is not treated early and aggressively. Diagnosing psoriatic arthritis can be a tricky process ...

Objectives Oligoarticular psoriatic arthritis (PsA) is frequent but rarely studied. The objective was to assess the efficacy of apremilast in early oligoarticular PsA. Methods FOREMOST (NCT03747939) ...

For the progressive subset, additionally, the multivariable analysis highlighted baseline Disease Activity in PSoriatic Arthritis (IRR=1.05, p=0.006) and swollen joint count (IRR=1.07, p=0.034) as ...

We’ll discuss the distinct traits of psoriatic arthritis in Black patients, and the various environmental and genetic factors ...

Weight loss in RA may be due to weakness and fatigue. 2 The challenge of early recognition of RA is that it may be difficult to distinguish from other types of arthritis involving inflammation. Talk ...

Medicines that block TNF, interleukin-1, and interleukin-6 can improve the symptoms ... psoriatic arthritis. This type of arthritis usually starts between ages 30 and 50 but can start as early ...

psoriatic arthritis is most common in adults between ages 30 and 50, but it can strike the very young. Only early diagnosis ...

The most common adverse events were gastrointestinal and generally occurred early, were self-limiting and infrequently led to discontinuation ... Conclusions Apremilast was effective in the treatment ...

Objectives To investigate serum lipid profile in early, treatment-naïve psoriatic arthritis (PsA) and to determine whether changes in classical ... (table 1) (Table 1) Both early PsA and RA patients ...